Unknown OBSERVATIONAL NCT04200118

Epigenetic and Genetic Effects in Cancer Patients: Analysis Pre and After Treatment

Sponsor: IVI Barcelona

Conditions Cancer Epigenetic Disorder Male Infertility

Updated 5 times since 2020 Last updated: Dec 13, 2019 Started: Nov 29, 2019 Primary completion: Apr 30, 2020 Completion: Apr 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cancer and Epigenetic Disorder, this trial is ongoing. The trial is conducted by IVI Barcelona and has accumulated 5 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting
Jan 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IVI Barcelona

Data source: IVI Barcelona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain